Global Allergy Diagnostics Market Segmentation, By Service (Assay Kits, Instruments, Services, Consumables), Tests (In-vivo Tests, In-vitro Tests), Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), End-User (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, Other End Users) - Industry Trends and Forecast to 2031.
Allergy Diagnostics Market Analysis
According to the WHO (World Health Organization), nearly 80% of the world's population lives in cities, and as a result, air quality has a significant impact on them, particularly in low-income nations. Furthermore, numerous research have demonstrated a link between air pollution and allergic rhinitis, asthma, and other illnesses, resulting in an increase in allergy diagnoses.
Allergy Diagnostics Market Size
Global allergy diagnostics market size was valued at USD 5.94 billion in 2023 and is projected to reach USD 13.90 billion by 2031, with a CAGR of 11.22% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Allergy Diagnostics Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Thermo Fisher Scientific (US), Siemens (Germany), Danaher (US), Omega Diagnostics Group PLC (US), Minaris Medical America, Inc. (US), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN Medizinische Labordiagnostika AG (Germany), INDOOR Biotechnologies, Inc. (India), Dr. Fooke Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medizin GmbH (Germany), Astra Biotech GmbH (Germany)
|
Allergy Diagnostics Market Definition
In medical terms, an allergy is defined as a systemic sensitivity disease. An allergy diagnosis is a test performed by a qualified allergy specialist to determine if the patient's body is allergic to any known chemicals. Allergy is frequently diagnosed via a diagnostic test or a biopsy. An elimination diet can also be used to achieve this goal.
Allergy Diagnostics Market Dynamics
Drivers
- Increased prevalence and heavy economic burden of allergic diseases
Because of the higher exposure to environmental pollutants in cities, the prevalence of allergy disorders among city dwellers is higher than among rural dwellers.
- Growing environmental pollution levels
The main risk factors for chronic respiratory disorders are exposure to indoor and outdoor air pollution, allergies, and occupational exposure.
- Rise in the access to health insurance
Substantial hospitals and diagnostic laboratories have a larger proportion of this market since they can afford high-volume systems due to their large capital budgets.
Opportunities
In addition, the growing usage of mHealth in allergy diagnosis are further estimated to provide potential opportunities for the growth of the allergy diagnostics market in the coming years.
Restraints/Challenges
On the other hand, the increased costs regarding the allergy diagnostic instruments is further projected to impede the growth of the allergy diagnostics market in the targeted period. However, the dearth of allergists might further challenge the growth of the allergy diagnostics market in the near future.
This allergy diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the allergy diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Allergy Diagnostics Market
The COVID-19 had a negative impact on the allergy diagnostics market. Due to the global spread of COVID, the market for allergy diagnostics has seen a little reduction. In most allergic disorders, diagnostic procedures were postponed because afflicted individuals were well-informed about avoiding probable environmental triggers and treating acute episodes, both of which were based on written action plans. However, as soon as the pandemic was under control, diagnostic processes were resumed.
Allergy Diagnostics Market Scope
The allergy diagnostics market is segmented on the basis of product and service, tests, allergen, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Service
- Assay Kits
- Instruments
- Services
- Consumables
On the basis of product and service, the allergy diagnostics market is segmented into assay kits, instruments, services, and consumables.
Tests
- In-vivo Tests
- In-vitro Tests
On the basis of age tests, the allergy diagnostics market is segmented into in-vivo tests and in-vitro tests.
Allergen
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Other Allergens
On the basis of allergen, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens.
End User
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Academic Research Institutes
- Other End Users
On the basis of end user, the allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users.
Allergy Diagnostics Market Regional Analysis
The allergy diagnostics market is analysed and market size insights and trends are provided by country, product and service, tests, allergen, and end user as referenced above.
The countries covered in the allergy diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the allergy diagnostics market due to the increase in the incidence of respiratory allergic disorders. Furthermore, the growing awareness levels related to the allergy diagnostics and the adoption of in vitro blood tests will further boost the growth of the allergy diagnostics market in the region during the forecast period.
Asia-Pacific is projected to observe a significant amount of growth in the allergy diagnostics market due to the rapid change in the improving of healthcare infrastructure. Moreover, the untapped clinical needs and the growing need for minimally invasive diagnostic tools is further anticipated to propel the growth of the allergy diagnostics market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The allergy diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for allergy diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the allergy diagnostics market. The data is available for historic period 2010-2020.
Allergy Diagnostics Market Share
The allergy diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to allergy diagnostics market.
Allergy Diagnostics Market Leaders Operating in the Market Are:
- Thermo Fisher Scientific (US)
- Siemens (Germany)
- Danaher (US)
- Omega Diagnostics Group PLC (US)
- Minaris Medical America, Inc. (US)
- bioMérieux SA (France)
- Stallergenes Greer (UK)
- HOB Biotech Group Corp., Ltd. (China)
- HYCOR Biomedical (US)
- Lincoln Diagnostics, Inc. (US)
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- INDOOR Biotechnologies, Inc. (India)
- Dr. Fooke Laboratorien GmbH (Germany)
- R-Biopharm AG (Germany)
- GA Generic Assays GmbH (Germany)
- Tecan Trading AG (Switzerland)
- DST Diagnostische Systeme & Technologien GmbH (Germany)
- ROXALL Medizin GmbH (Germany)
- Astra Biotech GmbH (Germany)
Latest Developments in Allergy Diagnostics Market
- In 2021, Minaris Medical America, Inc. has replaced Hitachi Chemical Diagnostics, Inc. Hitachi hopes to strengthen its global position and grow commercial operations in the field of in-vitro diagnostics by combining the medical business group firms under the brand Minaris Medical. Showa Denko Materials Co., Ltd. owns both firms
SKU-